Drugs / mCPP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03962829 Comparator | Feb 2019 → Mar 2020 | eating disorder, obesity disorder | University of Birmingham | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mCPP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03962829 ↗ |
| Action | Activate | “a 5-HT2C receptor agonist” NCT03962829 ↗ |
| Route | Oral | “oral administrating mCPP” NCT03962829 ↗ |